Letter from the Editor : Bioengineered Bugs begins …
Bioengineered bugs, drugs and contentious issues in patenting
Recombinant bacteriophage lysins as antibacterials
Receptor mimicry as novel therapeutic treatment for biothreat agents
Bacillus thuringiensis A genomics and proteomics perspective
Optimal epitope composition after antigen screening using a live bacterial delivery vector Application to TRP-2
In vivo persistence and protective efficacy of the bacille Calmette Guerin vaccine overexpressing the HspX latency antigen
Efficacy of a Lactococcus lactis Δ pyrG vaccine delivery platform expressing chromosomally integrated hly from Listeria monocytogenes
Biocontainment strategies for live lactic acid bacteria vaccine vectors